Published in Cardiovascular Week, November 6th, 2006
Study 1: Serum markers of vascular inflammation in dyslipemia are presented in a review published in a recent issue of Clinica Chimica Acta.
A report from Spain notes, "Atherosclerosis is widely recognized as an inflammatory disease because systemic and local inflammatory events mediate all phases of plaque development and progression. Basic and clinical studies have focused on identifying potentially useful markers of inflammation."
"In this article," wrote G. Francisco and colleagues at University Hospital Vall d'Hebron of Barcelona,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.